Premature aortic stiffness in systemic lupus erythematosus by transesophageal echocardiography

C A Roldan, J Joson, C R Qualls, J Sharrar, W L Sibbitt Jr, C A Roldan, J Joson, C R Qualls, J Sharrar, W L Sibbitt Jr

Abstract

To assess aortic stiffness by transesophageal echocardiography (TEE) and to determine its clinical predictors and relation to age, blood pressure, renal function, and atherosclerosis, 50 patients with systemic lupus erythematosus (SLE), 94% women, with a mean age of 38 ± 12 years, and 22 age and gender-matched healthy controls underwent clinical and laboratory evaluations and multiplane TEE to assess stiffness, intima-media thickness (IMT), and plaques of the proximal, mid, and distal descending thoracic aorta. Stiffness at each level and overall aortic stiffness by the pressure-strain elastic modulus was higher in patients than in controls after adjusting for age (overall, 8.25 ± 4.13 versus 6.1 ± 2.5 Pascal units, p = 0.01). Patients had higher aortic stiffness than controls after adjusting both groups to the same mean age, blood pressure, creatinine, and aortic IMT (p = 0.005). Neither IMT nor plaques were predictors of aortic stiffness. Moreover, normotensive patients, those without aortic plaques, and non-smokers had higher stiffness than controls (all p < 0.05). Age at SLE diagnosis and non-neurologic damage score were the only SLE-specific independent predictors of aortic stiffness (both p ≤ 0.01). Thus, increased aortic stiffness is an early manifestation of lupus vasculopathy that seems to precede the development of hypertension and atherosclerosis.

Trial registration: ClinicalTrials.gov NCT00858884.

Figures

Figure 1. Measurement of Aortic Diameters and…
Figure 1. Measurement of Aortic Diameters and Intima-media Thickness
This TEE short axis two-dimensional guided M-mode image of the proximal descending thoracic aorta in a patient with SLE demonstrates the measurements of the aortic systolic diameter (sD) at the peak of the T wave on the electrocardiogram and measurement of the diastolic diameter (dD) and aortic intima-media thickness (IMT) during end-diastole (after the P wave on the electrocardiogram). The systolic and diastolic diameters and IMT measured 1.8 cm, 1.6 cm, and 0.6 mm, respectively.
Figure 2. Pressure-Strain Elastic Modulus at the…
Figure 2. Pressure-Strain Elastic Modulus at the Proximal, Middle, and Distal Descending Thoracic Aorta in Patients with SLE and Controls
Note that the pressure strain elastic modulus (PSEM, mean ± SE) is higher in patients (blue line) than in controls (pink line) at every aortic location. Also note that PSEM progressively increases from the proximal to distal aorta. Unadjusted, p = 0.002 for group and p = 0.05 for location. Adjusted for age, p = 0.02 for group and p = 0.04 for location.
Figure 3. Pressure-Strain Elastic Modulus in Patients…
Figure 3. Pressure-Strain Elastic Modulus in Patients and Controls after Adjusting Both Groups to the Same Age, Blood Pressure, Renal Function, and Aortic Intima-media Thickness
SLE patients (blue line) had significantly higher PSEM (mean ± SE) than controls (pink line) at every aortic location (p = 0.005) and a linear trend up of PSEM from proximal to distal aorta was noted (p = 0.04).

References

    1. Becker-Merok A, Nossent J. Prevalence, predictors and outcome of vascular damage in systemic lupus erythematosus. Lupus. 2009;18:508–515.
    1. Urowitz MB, Gladman D, Ibañez D, et al. Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort. Lupus. 2007;16:731–735.
    1. Selzer F, Sutton-Tyrrell K, Fitzgerald SG, et al. Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus. Arthritis Rheum. 2004;50:151–159.
    1. Asanuma Y, Oeser A, Shintani AK, et al. Premature coronary artery atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003;349:2407–2415.
    1. Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003;349:2399–2406.
    1. Ippolito A, Petri M. An update on mortality in systemic lupus erythematosus. Clin Exp Rheumatol. 2008;(5 Suppl 51):S72–S79.
    1. Nossent J, Cikes N, Kiss E, et al. Current causes of death in systemic lupus erythematosus in Europe, 2000--2004: relation to disease activity and damage accrual. Lupus. 2007;16:309–317.
    1. Bjarnegråd N, Bengtsson C, Brodszki J, Sturfelt G, Nived O, Länne T. Increased aortic pulse wave velocity in middle aged women with systemic lupus erythematosus. Lupus. 2006;15:644–650.
    1. Yildiz M, Yildiz BS, Soy M, Tutkan H. Impairment of arterial distensibility in premenopausal women with systemic lupus erythematosus. Kardiol Pol. 2008;66:1194–1199.
    1. Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236–1241.
    1. Godia EC, Madhok R, Pittman J, et al. Carotid artery distensibility: a reliability study. J Ultrasound Med. 2007;26(9):1157–1165.
    1. Manzi S, Selzer F, Sutton-Tyrrell K, et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum. 1999;42:151–160.
    1. Selzer F, Sutton-Tyrrell K, Fitzgerald S, Tracy R, Kuller L, Manzi S. Vascular stiffness in women with systemic lupus erythematosus. Hypertension. 2001;37:1075–1082.
    1. Ryan MJ. The pathophysiology of hypertension in systemic lupus erythematosus. Am J Physiol Regul Integr Comp Physiol. 2009;296:R1258–R1267.
    1. Protogerou A, Blacher J, Stergiou GS, Achimastos A, Safar ME. Blood response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in regression of arterial stiffness in a controlled double blind) study. J Am Coll Cardiol. 2009;53:445–454.
    1. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in Hypertension Prevalence, Awareness, Treatment, and Control Rates in United States Adults Between 1988–1994 and 1999–2004. Hypertension. 2008;52:818–827.
    1. Zhang CY, Lu LJ, Li FH, et al. Evaluation of Risk Factors That Contribute to High Prevalence of Premature Atherosclerosis in Chinese Premenopausal Systemic Lupus Erythematosus Patients. J Clin Rheumatol. 2009;15:111–116.
    1. Cacciapaglia F, Zardi EM, Coppolino G, et al. Stiffness parameters, intima-media thickness and early atherosclerosis in systemic lupus erythematosus patients. Lupus. 2009;18:249–256.
    1. El-Magadmi M, Bodill H, Ahmad Y, et al. Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women. Circulation. 2004;110:339–404.
    1. Booth AD, Wallace S, McEniery CM, Yasmin, Brown J, Jayne DR, Wilkinson IB. Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation. Arthritis Rheum. 2004;50:581–588.
    1. Kabakov AE, Tertov VV, Saenko VA, Poverenny AM, Orekhov AN. The atherogenic effect of lupus sera: systemic lupus erythematosus-derived immune complexes stimulate the accumulation of cholesterol in cultured smooth muscle cells from human aorta. Clin Immunol Immunopathol. 1992;63:214–220.
    1. Avalos I, Chung CP, Oeser A, et al. Aspirin therapy and thromboxane biosynthesis in systemic lupus erythematosus. Lupus. 2007;16:981–986.
    1. Ferreira GA, Navarro TP, Telles RW, Andrade LE, Sato EI. Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: an 8 weeks controlled trial. Rheumatology (Oxford) 2007;46:1560–1565.

Source: PubMed

3
Abonner